Jpmorgan Chase & Co »

Trisalus Life Sciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $103k 11k 9.75

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Trisalus Life Sciences

Duquesne Family Office
Vanguard Group
Geode Capital Management
HC Advisors
Goldman Sachs Group
Connecticut Wealth Management
BlackRock
Wetherby Asset Management
Northern Trust
Anson Capital
Millennium Management
Cambridge Investment Research Advisors
Morgan Stanley
Jpmorgan Chase & Co
Tyche Wealth Partners

View all funds holding Trisalus Life Sciences